| Roche Pharma (Schweiz) AG - Esbriet 801 mg, Filmtabletten | | 66422 | | 03 | | Esbriet 801 mg | | Filmtabletten | | L04AX05 | | Pirfenidone | | 08.11.2017 | | |
| | Composition | | Filmtablette: pirfenidonum 801 mg, cellulosum microcristallinum, silica colloidalis anhydrica, povidonum K 30, carmellosum natricum conexum corresp. natrium 1.17 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose | additional_information |
|---|
| | 801 mg | Filmtablette |
| | BAG: Active Agent | Dose |
|---|
| | 801 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | Macrogol | 3350 | | | | | | | | | Überzug | | | 30 | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | 90 | 2357.01 | 2579.80 | B | SL | No |
|
|
